Novartis drug Afinitor®; approved by FDA as first medication for children and adults with a benign brain tumor associated with tuberous sclerosis
[Source: Novartis ]
211
ADD STORY TO CART
30-Oct-2010
Novartis announced that the US Food and Drug Administration (FDA) has approved Afinitor®; (everolimus) tablets for patients with subependymal giant cell astrocytoma (SEGA), a benign brain tumor associated with tuberous sclerosis (TS), who require therapeutic intervention but are not candidates for curative surgical resection. Available material includes soundbites.
Related Links & Documents
Novartis
Media releases
Press releasePDF
Related Media
    1 of 1    
Vicky Whittemore, PhD and Kari Luther Rosbeck: TS Alliance
Soundbites from Vicky Whittemore, PhD and Kari Luther Rosbeck: TS Alliance
[Source: Novartis]
TRT:00:04:27More
Debora Moritz, Mother of SEGA Patient
Soundbites from Debora Moritz, Mother of SEGA Patient
[Source: Novartis]
TRT:00:05:15More